Schedule 13G ownership disclosure

Achieve Life Sciences Inc

Common Stock · CUSIP: 004468500

Event date: 2025-03-31

Filing-level shares
1,717,014
Percent of class
4.95%
  • The Vanguard Group

    Shares: 1,717,014 · Class: 4.95%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000503
Form type
SCHEDULE 13G/A
Filer
ACHIEVE LIFE SCIENCES, INC.
CIK
CIK 949858
Filed
Apr 30, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub